Inari Medical, Stryker Subsidiary, Launches New InThrill Thrombectomy System

Reuters
29 Jul
Inari Medical, Stryker Subsidiary, Launches New InThrill Thrombectomy System

Inari Medical, now a subsidiary of Stryker Corporation, has unveiled its latest innovation, the InThrill® Thrombectomy System. This next-generation system is specifically designed for arteriovenous access and small vessel thrombus cases. The InThrill Thrombectomy System is an 8 French over-the-wire system that includes a thrombectomy catheter and sheath, engineered to become the standard in its field due to its efficiency and clot removal capabilities. Key features of the InThrill system include increased radial force for enhanced luminal wall apposition, an offset single open mouth for optimized clot capture, internal struts for even clot distribution, and a redesigned backend for improved ergonomics. The first commercial use of this system was successfully carried out by Dr. Joshua Pinter and Dr. Anish Ghodadra of the UPMC health care system, marking a significant advancement in thrombectomy procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stryker Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: DE38727) on July 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10